Warnings
Heroin; Morphine; 3-MAM
Zistené Heroin, Morphine, 3-MAM. Poloha: Švajčiarsko. Dátum: 2025-10-21. Zdroj: drugchecking.ch.
Appearance
- Media: 1 sample photo
Detected Substances
- Heroin
- Morphine
- 3-MAM
Expected vs Detected
No expected substance was recorded for this sample.
Detected result: Heroin, Morphine, 3-MAM
Sample Details
No additional sample descriptors available.
Testing Context
- Location: Švajčiarsko
- Date tested: 2025-10-21
- Source: drugchecking.ch
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
356 súvisiacich varovaní · Dozviete sa viac o bežných nečistotách.
- HeroinZistené
- MorphineZistené
- 3-MAMZistené
Súvisiace vzorky a kombinácie
3-MAM + 6-MAM + Heroin + Morphine
Spoločne zistené v súvisiacich výsledkoch kontrol dávok.
6-MAM + Acetylcodeine + Caffeine + Heroin + Morphine + Noscapine + Papaverine + Paracetamol
Spoločne zistené v súvisiacich výsledkoch kontrol dávok.
- Acetylcodeine + Heroin + 6-MAM + Noscapine + Caffeine + Morphine + Papaverine + Paracetamol
- Acetylcodeine + Caffeine + Heroin + 6-MAM + Noscapine + Papaverine + Paracetamol + Morphine
- 6-MAM + Acetylcodeine + Caffeine + Heroin + Morphine + Noscapine + Papaverine + Paracetamol
- Heroin + Caffeine + Paracetamol + Noscapine + 6-MAM + Papaverine + Acetylcodeine + Morphine
6-MAM + Acetylcodeine + Caffeine + Diazepam + Heroin + Morphine + Noscapine + Papaverine + Paracetamol
Spoločne zistené v súvisiacich výsledkoch kontrol dávok.
6-MAM + Acetylcodeine + Caffeine + Cocaine + Codeine + Dextromethorphan + Heroin + Morphine + Noscapine + Papaverine
Spoločne zistené v súvisiacich výsledkoch kontrol dávok.
6-MAM + Acetylcodeine + Caffeine + Codeine + Heroin + Morphine + Noscapine + Papaverine + Paracetamol
Spoločne zistené v súvisiacich výsledkoch kontrol dávok.
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.
